InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Notman Donald, Chief Financial Officer. Director active across 2 companies, notably OCULAR THERAPEUTIX, INC. In total, 12 disclosures have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €243k. Activity tracked since 3 February 2022. The latest transaction was disclosed on 12 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Donald Notman is the Chief Financial Officer at Ocular Therapeutix, Inc. He is responsible for the financial management of the company, including financial planning and performance analysis. His expertise in finance is essential to support the company's strategic goals.